ARCHIVES

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

September 3, 2010

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Freireich, Moertel Matched Up Again

February 20, 1981

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979